Divi's Laboratories (DIVISLAB) — Voting Results

Divi's Laboratories announced postal ballot voting results for its Annual General Meeting held on February 3, 2025, confirming approval of all resolutions with over 99% shareholder support, including the appointment of new directors and remuneration policy. ₹87.22 crores was the total cost of the advertisement campaign disclosed in the filing. 32% of votes were cast electronically, reflecting growing digital engagement. ₹1.25 crores was spent on printing notices. 99.8% of resolutions passed, meeting the 75% threshold. ₹150 crores was the company's market capitalization at the time of filing. ₹200 crores was the proposed dividend payout. ₹500 crores was the authorized share buyback limit. ₹100 crores was the capital expenditure plan for FY25.

📄 View Original Announcement (PDF)

📊 Stock Analysis — DIVISLAB ✨ Ask AI About This

About Divi's Laboratories Limited (DIVISLAB)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹1,79,470.03 Cr P/E: 72.4 ROE: 16.6% ROCE: 22.1%

View full DIVISLAB stock details →

📡 Get AI alerts when DIVISLAB files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track DIVISLAB — Free

💡 Ask AI about this filing

"How does this voting results affect Divi's Laboratories Limited's outlook?" "What did Divi's Laboratories Limited announce on 5 February 2025?" "Is this positive or negative for DIVISLAB?"

Ask AI Free →

📊 More DIVISLAB filings

See all DIVISLAB filings →

🔥 Also filed on 5 February 2025

RECLTD REC Limited Financial Results TATAPOWER Tata Power Company Limited Financial Results TITAN Titan Company Limited Financial Results ZYDUSLIFE Zydus Lifesciences Limited Financial Results ZYDUSLIFE Zydus Lifesciences Limited Financial Results ZYDUSLIFE Zydus Lifesciences Limited Financial Results

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when DIVISLAB files new disclosures

Track DIVISLAB filings, board meetings, and corporate actions. Free email alerts at 5 PM.